Messerschmid, Roman,Brox, Werner,Bock, Thomas,Binder, Rudolf
申请号：
AU2015227503
公开号：
AU2015227503B2
申请日:
2015.09.18
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
#$%^&*AU2015227503B220170223.pdf#####CAPSULE PHARMACEUTICAL DOSAGE FORM COMPRISING A SUSPENSION FORMULATION OF AN INDOLINONE DERIVATIVE ABSTRACT The present invention relates to a suspension formulation containing the active substance 3-Z-[1(4-(N-(( 4-methylpiperazin- 1 -yl)-methylcarbonyl)-N-methyl-amino)-anilino)- 1 -phenylmethylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate, to a capsule pharmaceutical dosage form containing said suspension formulation, to a process for preparing said suspension formulation, to a process for preparing said capsule comprising said suspension formulation and to the packaging material for the finished capsule.
